Published
2025-01-22
Section
Articles
How to Cite
Impact of Urbanization and Dietary Transitions on Metabolic Syndrome and Insulin Resistance in Bangladesh: A Cross-Sectional Study
Hassan IsmailAbdi
Hassan Ismail Abdi, Department of Public Health, World University of Bangladesh (WUB), Bangladesh, hassan2020sym@gmail.com
Mohamed NurMohamed
Mohamed Nur Mohamed, Department of Public Health, World University of Bangladesh (WUB), Bangladesh, mohamednuur9920@gmail.com
Md. AshiqurRahman
Md. Ashiqur Rahman, Department of Laboratory Medicine, Novus Clinical Research Services Limited, Bangladesh, ararashiqur@gmail.com
Shohanur Rahaman
Shohanur Rahaman, Department of Molecular, BIHS General Hospital, Bangladesh, shohanbuhs@gmail.com
Sadia Islam
Sadia Islam, Department of Laboratory Medicine, Bangladesh Specialized Hospital PLC, Bangladesh, sadia.buhs.6700@gmail.com
Keywords: Metabolic Syndrome (MetS); Insulin Resistance (IR); Urbanization; Lifestyle Changes; Biochemical Markers
Abstract
Background: Metabolic Syndrome (MetS) is a group of conditions, including obesity, dyslipidemia, hypertension, and impaired glucose metabolism, that raise the risk of cardiovascular disease and type 2 diabetes. Its prevalence is rising globally due to obesity, sedentary lifestyles, and poor diets, especially in urbanizing countries like Bangladesh. In Bangladesh, urbanization and lifestyle changes are worsening the prevalence of MetS and insulin resistance, with the South Asian phenotype further increasing vulnerability. Objective: The study aims to evaluate the prevalence and determinants of Metabolic Syndrome and insulin resistance among Bangladeshi adults, focusing on the effects of urbanization, diet, and lifestyle, and to propose targeted public health interventions for prevention and management. Methods: This cross-sectional study, conducted from February 2021 to March 2022, involved 220 participants aged 20-60. Of these, 98 had Metabolic Syndrome (MetS) and 122 did not. Data included anthropometric and biochemical measurements. Statistical analysis using SPSS (version 23) considered p-values
References
1.Alberti, K. G. M. M., Zimmet, P. Z., & Shaw, J. (2009). Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetes Medicine, 23(5), 469-480.
2.DeFronzo, R. A., Ferrannini, E., & Groop, L. (2005). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 1, 15019.
3.Hanley, A. J. G., Williams, K., & Stern, M. P. (2002). Identification of subjects with insulin resistance syndrome using alternative definitions of the metabolic syndrome. Diabetes, 51(10), 3356-3364.
4.Kaur, J. (2014). A comprehensive review on metabolic syndrome. Cardiovascular Endocrinology & Metabolism, 3(4), 239-250.
5.Lee, D. H., Ha, M. H., & Kim, J. H. (2003). Gamma-glutamyl transferase and diabetes: a meta-analysis. Diabetes Care, 26(11), 3505-3510.
6.Shamrin T, NurMohamed M, BakarSiddik A, Islam S, Sarker N, Halder S, Akter T, AshiqurRahman M. Serum Gamma-Glutamyl Transferase as a Predictive Biomarker for Metabolic Syndrome and Insulin Resistance: Implications for Early Risk Assessment and Preventive Healthcare. Molecular Mechanism Research. 2024 Nov 25;2(2).
7.Misra, A., & Khurana, L. (2008). Obesity and the metabolic syndrome in developing countries. Journal of Clinical Endocrinology & Metabolism, 93(11), 3670-3678.
8.Morrison, J. A., Friedman, L. A., & Gray-McGuire, C. (2011). Metabolic syndrome in children and adolescents. International Journal of Obesity, 35(1), 7-16.
9.AliMohamud A, NurMohamed M, AshiqurRahman M, Islam S. Serum Gamma-Glutamyl Transferase as a Biomarker for Insulin Resistance and Metabolic Syndrome in Dhaka, Bangladesh: A Cross-Sectional Study. Molecular Mechanism Research. 2024 Nov 22;2(1).
10.Sowers, J. R., Epstein, M., & Frohlich, E. D. (2009). Diabetes, hypertension, and cardiovascular disease: an update. Hypertension, 54(5), 622-629.
11.Wilson, P. W. F., D'Agostino, R. B., & Parise, H. (1999). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 104(14), 1997-2001.
12.Chanda M, Biswas T, Tannim N, MahbubaA, Yasmin R, Islam S, Rahman MA.Association of Serum Uric Acid and LipidProfile in Adults at a Tertiary Level Hospitalin Bangladesh. Ad-din Sakina Women’sMedical College Journal. 2024; 5(1): 28-37.
13.Park, Y.W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M.R. and Heymsfield, S.B., 2003. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine, 163(4), pp.427-436.
14.Kavsak, P., 2017. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, edited by Nader Rifai, Andrea Rita Horvath and Carl T. Wittwer,6th edn, Elsevier, St. Louis, Missouri, USA.
15.Nestel, P., Lyu, R., Low, L.P., Sheu, W.H.H., Nitiyanant, W., Saito, I. and Tan, C.E., 2007. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pacific Journal of Clinical Nutrition, 16(2), pp.362-367.
16.Mainuddin, A.K.M., Choudhury, K.N., Ahmed, K.R., Akter, S., Islam, N. and Masud, J.H.B., 2013. The metabolic syndrome: comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements. Cardiovascular Journal, 6(1), pp. 17-22.
17.Chowdhury, M.Z.I., Anik, A.M., Farhana, Z., Bristi, P.D., Al Mamun, B.A., Uddin, M.J., Fatema, J., Akter, T., Tani, T.A., Rahman, M. and Turin, T.C., 2018. Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. BMC Public Health, 18(1), p.308.
18.Borai, A., Livingstone, C. and Ferns, G.A., 2007. The biochemical assessment of insulin resistance. Annals of Clinical Biochemistry, 44(4), pp.324-342.
19.Lee, D.H., Blomhoff, R. and Jacobs, D.R., 2004. Review is serum gamma glutamyltransferase a marker of oxidative stress. Free Radical Research, 38(6), pp.535-539.
20.Nakanishi, N., Suzuki, K. and Tatara, K., 2004. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care, 27(6), pp.1427-1432.
21.Inoue, K., Hirohara, J., Nakano, T., Seki, T., Sasaki, H., Higuchi, K., Ohta, Y., Onji, M., Muto, Y. and Moriwaki, H., 1995. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver, 15(2), pp.70-77.
22.Shamrin T, NurMohamed M, BakarSiddik A, Islam S, Sarker N, Halder S, Akter T, AshiqurRahman M. Serum Gamma-Glutamyl Transferase as a Predictive Biomarker for Metabolic Syndrome and Insulin Resistance: Implications for Early Risk Assessment and Preventive Healthcare. Molecular Mechanism Research. 2024 Nov 25;2(2).